Access

Article

Nature 435, 646-651 (2 June 2005) | doi:10.1038/nature03556; Received 17 November 2004; Accepted 18 March 2005; Published online 3 April 2005

Open Innovation Challenges

naturejobs

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

Fyodor D. Urnov1, Jeffrey C. Miller1, Ya-Li Lee1, Christian M. Beausejour1, Jeremy M. Rock1, Sheldon Augustus1, Andrew C. Jamieson1, Matthew H. Porteus2, Philip D. Gregory1 & Michael C. Holmes1

  1. Sangamo BioSciences, Inc. Pt. Richmond Tech Center 501, Canal Blvd, Suite A100 Richmond, California 94804, USA
  2. Department of Pediatrics and Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas 75390, USA

Correspondence to: Michael C. Holmes1 Correspondence should be addressed to M.C.H. (Email: mholmes@sangamo.com) or M.H.P. (Email: matthew.porteus@UTSouthwestern.edu); requests for materials should be addressed to M.C.H.

Top

Permanent modification of the human genome in vivo is impractical owing to the low frequency of homologous recombination in human cells, a fact that hampers biomedical research and progress towards safe and effective gene therapy. Here we report a general solution using two fundamental biological processes: DNA recognition by C2H2 zinc-finger proteins and homology-directed repair of DNA double-strand breaks. Zinc-finger proteins engineered to recognize a unique chromosomal site can be fused to a nuclease domain, and a double-strand break induced by the resulting zinc-finger nuclease can create specific sequence alterations by stimulating homologous recombination between the chromosome and an extrachromosomal DNA donor. We show that zinc-finger nucleases designed against an X-linked severe combined immune deficiency (SCID) mutation in the IL2Ritalic gamma gene yielded more than 18% gene-modified human cells without selection. Remarkably, about 7% of the cells acquired the desired genetic modification on both X chromosomes, with cell genotype accurately reflected at the messenger RNA and protein levels. We observe comparably high frequencies in human T cells, raising the possibility of strategies based on zinc-finger nucleases for the treatment of disease.

  1. Sangamo BioSciences, Inc. Pt. Richmond Tech Center 501, Canal Blvd, Suite A100 Richmond, California 94804, USA
  2. Department of Pediatrics and Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas 75390, USA

Correspondence to: Michael C. Holmes1 Correspondence should be addressed to M.C.H. (Email: mholmes@sangamo.com) or M.H.P. (Email: matthew.porteus@UTSouthwestern.edu); requests for materials should be addressed to M.C.H.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

'Magic' scissors for genome surgery

Nature Biotechnology News and Views (01 Jun 2005)

Plant biotechnology Zinc fingers on target

Nature News and Views (21 May 2009)

See all 6 matches for News And Views